InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Currie Mark G, 董事. Director active across 1 company, notably Ironwood Pharmaceuticals INC. Cumulatively, 10 disclosures have been logged. Split: 0 buy · 2 sells. Total volume traded: €1m. History available since 2 June 2021. The latest transaction was filed on 10 June 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Currie Mark G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
63,481 股Class A Common StockSEC:0001193125-26-274288:0
45,000 股0Class A Common StockSEC:0000950170-25-085440:0
24,311 股0Class A Common StockSEC:0000950170-24-076206:0
22,350 股0Class A Common StockSEC:0001209191-23-039132:0
70,000 股@ US$11.7824.1% 占其流量Class A Common StockSEC:0001209191-22-045808:0
190,383 股@ US$11.650.35% mcap82.1% 占其流量Class A Common StockSEC:0001209191-22-035443:0
21,571 股0Class A Common StockSEC:0001209191-22-033983:0
23,571 股@ US$11.597.3% 占其流量Class A Common StockSEC:0001209191-21-040892:0
22,766 股0Class A Common StockSEC:0001209191-21-038179:0
64,102 股Class B Common StockSEC:0001209191-16-090084:0
10 条申报中的 10 条
About Currie Mark G
Currie Mark G is Administrateur at Ironwood Pharmaceuticals INC (XNAS). Across 10 filings in total, the 10 sampled filings run from 2016-01-06 to 2026-06-17, with EUR 0 of buys and EUR 1024646 of sells in those recent filings; the most frequent transaction nature is Attribution.
